Day: April 6, 2020

CALGARY, Alberta, April 06, 2020 (GLOBE NEWSWIRE) — NXT Energy Solutions Inc. (“NXT” or the “Company”) (TSX:SFD; OTC QB:NSFDF) announces that the Company’s Annual Information Form and Annual Financial Statements, including Management’s Discussion and Analysis for the year ended December 31, 2019 (collectively, the “2019 Results”) will now be filed on Monday, April 13, 2020 after market close, and we will hold a conference call to discuss the 2019 Results on Tuesday, April 14, 2020 at 4:30 p.m. Eastern Time (2:30 p.m. Mountain Time). The 2019 Results would ordinarily have been filed on or before the March 30, 2020 deadline as required under the Canadian Securities Administrators National Instrument 51-102 Continuous Disclosure Obligations.  However, as NXT and its external service providers...

BRIDGEWATER, N.J., April 06, 2020 (GLOBE NEWSWIRE) — Menlo Therapeutics Inc. (Nasdaq: MNLO) (“Menlo” or the “Company”), a biopharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced top line results from two Phase 3 clinical trials evaluating the safety and efficacy of once daily oral serlopitant for the treatment of pruritus (itch) associated with prurigo nodularis (PN), studies MTI-105 and MTI-106. Study MTI-105 enrolled 285 patients in the US and study MTI-106 enrolled a total of 295 patients from Germany, Poland and Austria. Patients were randomized 1:1 to either serlopitant 5mg or placebo treatment.Study MTI-105 and Study MTI-106 did not meet their respective primary endpoint of demonstrating statistically significant reduction in pruritus...

REDMOND, Wash., April 06, 2020 (GLOBE NEWSWIRE) — MicroVision, Inc. (NASDAQ:MVIS), a leader in innovative ultra-miniature projection display and sensing technology, today announced it has retained investment banking firm Craig-Hallum Capital Group LLC to serve as its financial advisor as it explores various licensing and other strategic alternatives, including a potential sale or merger of the company.“As we reported on March 11, we are actively engaged with multiple interested parties to evaluate various opportunities to license our IP as well as other strategic alternatives. We have retained Craig-Hallum to advise us as we continue these efforts to maximize shareholder value,” said Sumit Sharma, MicroVision Chief Executive Officer.There can be no assurance regarding the timing or outcome of the strategic alternatives review process....

Combined Shareholders’ Meeting of April 30, 2020, without the physical presence of shareholdersParis, April 6, 2020 – Due to travel restrictions and the containment measures put in place by the French government to address the COVID-19 epidemic, the Board of Directors of Lectra, meeting today under the chairmanship of Daniel Harari, has decided that the Combined Shareholders’ Meeting of April 30, 2020, will exceptionally be held without the physical presence of the shareholders or other persons normally entitled to attend.The shareholders of Lectra are invited to vote by absentee ballot or to grant their proxy to the Chairman of the Shareholders’ Meeting, using the postal voting form or the proxy form. The form must be completed and signed, and returned by post to Société Générale Securities Services, subject to the...

Tenue de l’Assemblée générale mixte du 30 avril 2020 à huis closParis, le 6 avril 2020 – Compte tenu des restrictions de circulation et des mesures de confinement imposées par le Gouvernement dans le contexte de l’épidémie du COVID-19, le Conseil d’administration de Lectra, réuni ce jour sous la présidence de Monsieur Daniel Harari, a décidé que l’Assemblée générale mixte du 30 avril 2020 se tiendra exceptionnellement à huis clos, hors la présence physique des actionnaires et des autres personnes ayant le droit d’y assister.Les actionnaires de Lectra sont invités à voter à distance ou à donner pouvoir au Président de l’Assemblée générale, en utilisant le formulaire de vote par correspondance ou par procuration. Le formulaire complété et signé doit être retourné par voie postale à la Société Générale Securities Services, dans les conditions...

Reference is made to the private placement of 3,253,370 new shares towards Bomi Framroze (the “Private Placement”) in Hofseth BioCare ASA, as announced on 23 March 2020.The share capital increase relating to the Private Placement has now been registered with the Norwegian Register of Business Enterprises. The share capital has been increased with NOK 3,253,370 through issuance of 3,253,370 new shares, each with a par value of NOK 1.The new share capital is thus NOK 329,073,881 divided by 329,073,881 shares, each with a par value of NOK 1.This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.For further information, please contact:Jon Olav Ødegård, CFO of Hofseth BioCare ASAPhone: +47 936 32 966E-mail: joo@hofsethbiocare.noAbout Hofseth BioCare ASAHBC is...

HC2 Recommends StockholdersSign, Date and Promptly Return the WHITE Consent Revocation Card and Mark “REVOKE MY CONSENT” Boxes to Oppose Each of Percy Rockdale’s Proposals and Support HC2’s Independent, Experienced and Highly Qualified DirectorsNew York, April 06, 2020 (GLOBE NEWSWIRE) — HC2 Holdings, Inc. (“HC2” or the “Company”) (NYSE: HCHC), a diversified holding company, today filed its definitive consent revocation statement and issued a letter to stockholders highlighting the lack of constructive engagement by Percy Rockdale LLC and certain of its affiliates (collectively, “Percy Rockdale”), the Company’s progress towards improving its capital structure and steps it has taken to enhance the Company’s Board of Directors (the “Board”). Highlights from the letter include:HC2 has a truly independent Board accountable to all stockholders,...

GAITHERSBURG, Md., April 06, 2020 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE: EBS) today announced the appointment of Nina DeLorenzo to the position of senior vice president for global public affairs. DeLorenzo will oversee external relations, corporate communications, advocacy, and corporate social responsibility. She will be responsible for developing and leading the company’s global public affairs strategy and providing strategic communications counsel to the executive management team.Robert G. Kramer Sr., president and chief executive officer at Emergent BioSolutions, stated, “On behalf of the management team, I am pleased to welcome Nina to Emergent. Her deep bench of public affairs and public policy experience uniquely qualify her for this critical role, and we look forward to both her leadership and strategic counsel...

TORONTO, April 06, 2020 (GLOBE NEWSWIRE) — Firm Capital Mortgage Investment Corporation (the “Corporation”) (TSX: FC) announces its monthly dividend of $0.078 per share payable to Shareholders of record on April 30, 2020. The Corporation has in place a Dividend Reinvestment Plan (“DRIP”) and Share Purchase Plan that is available to its shareholders.  Shareholders are reminded that they can participate in the Corporation’s Dividend Reinvestment Plan and Share Purchase Plan.  Participant shareholders pay no commission for shares issued from treasury.DIVIDEND REINVESTMENT PLAN (DRIP)The DRIP allows participants to have their monthly cash dividends reinvested in additional shares of the Corporation.  A 3% discount will only apply if the weighted average trading price, calculated five trading days immediately preceding each...

Please be informed that the Board of AB Klaipėdos nafta (hereinafter – the Company) approved new alternative draft decisions on 10 April 2020 Extraordinary General Meeting of Shareholders agenda item No 1, by which shareholders are given right to sign share subscription agreements with an electronic signature.In light of the fact that a lockdown has been extended in the Republic of Lithuania in accordance with Resolution No 264 of 25 March 2020 of the Government of the Republic of Lithuania, it is recommended that all shareholders participate in the meeting by completing the general ballot paper and submitting it in advance to the Company (Annex No 2).Please inform us about the need to physically attend the General Meeting of Shareholders no later than 3 business days before General Meeting of Shareholders via emails: i.berzauskas@kn.lt...